Neuralink's First Patient Speaks, and How to Invest in SpaceX | Elon, Inc.

Last week, Bloomberg Businessweek published an exclusive look at Noland Arbaugh, the first person to get Elon Musk’s Neuralink technology implanted in his head. Our own Ashlee Vance spent time with Arbaugh, who lives with his parents and (as you’ll hear) some vocal farm animals. Vance joins us to talk about what he learned from the first patient in Neuralink’s inaugural clinical trial. He is joined by Bloomberg’s Sarah McBride to give a full picture on what it all means. Plus, we talk to markets reporter Kiel Porter and space reporter Loren Grush about all of the action around SpaceX stock—which is kind of interesting since it’s still a private company.

Elon Musk’s sprawling business empire has granted the billionaire a degree of power and global influence that transcends the industries he’s reshaped. He is the leader of no fewer than six hugely influential companies, spanning electric vehicles to wartime communications, and their innovations could shape the fates of nations.

Musk is polarizing, confounding and inescapable. And he is the biggest business story of our time.

Each week, listen in as host David Papadopoulos convenes a panel of Bloomberg Businessweek journalists who are tracking Musk’s companies and the surprising ways they intersect. They break down the business mogul's latest moves and analyze what they could mean for us all.

Subscribe to Bloomberg Podcasts: https://bit.ly/BloombergPodcasts
Listen to more Elon, Inc.:    • Elon, Inc.  

#ElonMusk #Bloomberg #Podcast #Elon

Visit us: https://www.bloomberg.com/podcasts

Follow Bloomberg Podcasts on Twitter:   / podcasts  

Visit our other YouTube channels:
Bloomberg Television:    / @markets  
Bloomberg Originals:    / bloomberg  
Quicktake:    / @bloombergquicktake  

For coverage on news, markets and more: http://www.bloomberg.com/video